|
|
Reference
|
|
  
|
Allan, L.D. (2003) Cardiac anatomy screening: What is the best time for screening in pregnancy?. Curr Opin Obstet Gynecol, 15(2): 143-6
|
|
|
Antolin, E., Comas, C., Torrents, M., Munoz, A., Figueras, F., Echevarria, M., Cararach, M., Carrera, J.M. (2001) The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol, 17(4): 295-300
|
|
|
Audibert, F., Dommergues, M., Benattar, C., Taieb, J., Thalabard, J.C., Frydman, R. (2001) Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: A prospective longitudinal study. Ultrasound Obstet Gynecol, 18(1): 26-31
|
|
|
Bilardo, C.M., Muller, M.A., Zikulnig, L., Schipper, M., Hecher, K. (2001) Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: Relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol, 17(4): 288-94
|
|
|
Bronshtein, M., Zimmer, E.Z. (2002) The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol, 19(4): 360-5
|
|
|
Canini, S., Prefumo, F., Famularo, L., Venturini, P.L., Palazzese, V., de Biasio, P. (2002) Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies. Clin Chem Lab Med, 40(6): 600-3
|
|
|
Chitkara, U., Lee, L., Oehlert, J.W., Bloch, D.A., Holbrook, R.H., El-Sayed, Y.Y., Druzin, M.L. (2002) Fetal ear length measurement: A useful predictor of aneuploidy?. Ultrasound Obstet Gynecol, 19(2): 131-5
|
|
|
Cicero, S., Dezerega, V., Andrade, E., Scheier, M., Nicolaides, K.H. (2003) Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol, 22(2): 135-7
|
|
|
Cicero, S., Curcio, P., Papageorghiou, A., Sonek, J., Nicolaides, K. (2001) Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: An observational study. Lancet, 358(9294): 1665-7
|
|
|
Cicero, S., Bindra, R., Rembouskos, G., Spencer, K., Nicolaides, K.H. (2003) Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn, 23(4): 306-10
|
|
|
Cuckle, H. (2001) Integrating antenatal Down's syndrome screening. Curr Opin Obstet Gynecol, 13(2): 175-81
|
|
1
|
Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol, 94(5): 387-402
|
|
|
Cuckle, H.S., Wald, N.J., Lindenbaum, R.H. (1984) Maternal serum alpha-fetoprotein measurement: A screening test for Down syndrome. Lancet, 1(8383): 926-9
|
|
|
Ghezzi, F., Raio, L., di Naro, E., Franchi, M., Buttarelli, M., Schneider, H. (2002) First-trimester umbilical cord diameter: A novel marker of fetal aneuploidy. Ultrasound Obstet Gynecol, 19(3): 235-9
|
|
|
Huggon, I.C., Ghi, T., Cook, A.C., Zosmer, N., Allan, L.D., Nicolaides, K.H. (2002) Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol, 20(1): 22-9
|
|
3
|
Krantz, D.A., Hallahan, T.W., Orlandi, F., Buchanan, P., Larsen, J.W., Macri, J.N. (2000) First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol, 96(2): 207-13
|
|
|
Liao, A.W., Snijders, R., Geerts, L., Spencer, K., Nicolaides, K.H. (2000) Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol, 16(7): 610-3
|
|
|
Liao, A.W., Sebire, N.J., Geerts, L., Cicero, S., Nicolaides, K.H. (2003) Megacystis at 10-14 weeks of gestation: Chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol, 21(4): 338-41
|
|
|
Longo, D., DeFigueiredo, D., Cicero, S., Sacchini, C., Nicolaides, K.H. (2004) Femur and humerus length in trisomy 21 fetuses at 11-14 weeks of gestation. Ultrasound Obstet Gynecol, 23(2): 143-7
|
|
|
Matias, A., Montenegro, N. (2001) Ductus venosus blood flow in chromosomally abnormal fetuses at 11 to 14 weeks of gestation. Semin Perinatol, 25(1): 32-7
|
|
|
Matias, A., Huggon, I., Areias, J.C., Montenegro, N., Nicolaides, K.H. (1999) Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol, 14(5): 307-10
|
|
1
|
Matias, A., Gomes, C., Flack, N., Montenegro, N., Nicolaides, K.H. (1998) Screening for chromosomal abnormalities at 10-14 weeks: The role of ductus venosus blood flow. Ultrasound Obstet Gynecol, 12(6): 380-4
|
|
1
|
Merkatz, I.R., Nitowsky, H.M., Macri, J.N., Johnson, W.E. (1984) An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol, 148(7): 886-94
|
|
|
Metzenbauer, M., Hafner, E., Schuchter, K., Philipp, K. (2002) First-trimester placental volume as a marker for chromosomal anomalies: Preliminary results from an unselected population. Ultrasound Obstet Gynecol, 19(3): 240-2
|
|
|
Nicolaides, K.H., Snijders, R.J., Cuckle, H.S. (1998) Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn, 18(5): 519-23
|
|
1
|
Nicolaides, K.H. (2004) The 11-14 week scan. Fetal Medicine Foundation
|
|
|
Nicolaides, K.H., Sebire, N.J., Snijders, J.M. (1996) Crown rump length in chromosomally abnormal fetuses. u: Nicolaides K.H. (ur.) The 11-14-week scan: the diagnosis of fetal abnormalities, New York: Parthenon Publishing, str. 31-3
|
|
5
|
Nicolaides, K.H. (2004) Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol, 191(1): 45-67
|
|
|
Rembouskos, G., Cicero, S., Papadopoulos, V., Tripsanas, C., Nicolaides, K.H. (2004) Umbilical cord diameter at 11-14 weeks of gestation: Relation to chromosomal defects. Ultrasound Obstet Gynecol, 23(3): 237-9
|
|
|
Rembouskos, G., Cicero, S., Longo, D., Sacchini, C., Nicolaides, K.H. (2003) Single umbilical artery at 11-14 weeks' gestation: Relation to chromosomal defects. Ultrasound Obstet Gynecol, 22(6): 567-70
|
|
|
Sacchini, C., El-Sheikhah, A., Cicero, S., Rembouskos, G., Nicolaides, K.H. (2003) Ear length in trisomy 21 fetuses at 11-14 weeks of gestation. Ultrasound Obstet Gynecol, 22(5): 460-3
|
|
|
Shipp, T.D., Bromley, B., Lieberman, E., Benacerraf, B.R. (1998) The second-trimester fetal iliac angle as a sign of Down's syndrome. Ultrasound Obstet Gynecol, 12(1): 15-8
|
|
|
Snijders, R.J., Sebire, N.J., Souka, A., Santiago, C., Nicolaides, K.H. (1995) Fetal exomphalos and chromosomal defects: Relationship to maternal age and gestation. Ultrasound Obstet Gynecol, 6(4): 250-5
|
|
4
|
Spencer, K., Souter, V., Tul, N., Snijders, R., Nicolaides, K.H. (1999) A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol, 13(4): 231-7
|
|
4
|
Spencer, K., Spencer, C.E., Power, M., Moakes, A., Nicolaides, K.H. (2000) One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG, 107(10): 1271-5
|
|
1
|
Spencer, K., Spencer, C.E., Power, M., Dawson, C., Nicolaides, K.H. (2003) Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience. BJOG, 110(3): 281-6
|
|
|
Spencer, K., Cuckle, H.S. (2002) Screening for chromosomal anomalies in the first trimester: Does repeat maternal serum screening improve detection rates?. Prenat Diagn, 22(10): 903-6
|
|
|
Stojilkovic-Mikic, T., Rodeck, C.H. (2003) Screening for chromosomal anomalies: First or second trimester, biochemical or ultrasound?. Ann Acad Med Singapore, 32(5): 583-8; qui
|
|
|
Wald, N.J., Hackshaw, A.K. (2000) Advances in antenatal screening for Down syndrome. Baillieres Best Pract Res Clin Obstet Gynaecol, 14(4): 563-80
|
|
5
|
Wald, N.J., Rodeck, C., Hackshaw, A.K., Walters, J., Chitty, L., Mackinson, A.M. (2003) First and second trimester antenatal screening for Down's syndrome: The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess, 7(11): 1-77
|
|
2
|
Wald, N.J., Kennard, A., Hackshaw, A., McGuire, A. (1998) Antenatal screening for Down's syndrome. Health Technol Assess, 2(1): i-iv, 1-11
|
|
1
|
Wald, N.J., Cuckle, H.S., Densem, J.W., Nanchahal, K., Royston, P., Chard, T., Haddow, J.E., Knight, G.J., Palomaki, G.E., Canick, J.A. (1988) Maternal serum screening for Down's syndrome in early pregnancy. BMJ, 297(6653): 883-7
|
|
|
Wald, N.J., Huttly, W.J., Hackshaw, A.K. (2003) Antenatal screening for Down's syndrome with the quadruple test. Lancet, 361(9360): 835-6
|
|
|
Yeo, L., Guzman, E.R., Ananth, C.V., Walters, C., Day-Salvatore, D., Vintzileos, A.M. (2003) Prenatal detection of fetal aneuploidy by sonographic ear length. J Ultrasound Med, 22(6): 565-76; qu
|
|
|
|
|